Corporate Governance

QRxPharma has implemented a corporate governance framework consistent with the ASX best practice recommendations for listed companies to protect the interests of shareholders.

The Board comprises five directors, an independent non-Executive Chairman, two other non-Executive Directors, the Managing Director and one Director who is a Consultant to the Company.

QRxPharma's Board and Management bring together complementary skills and experience. This includes more than a century of experience in drug development and commercialisation, regulatory management, product sales and marketing in (bio)pharmaceutical companies, general business management, and governance of ASX-listed companies.

• Board Charter
• Nominations Committee Charter
• Remuneration Committee Charter
• Continuous Disclosure Policy
• Shareholder Communication Policy
• Securities Trading Policy
• Audit & Risk Committee Charter